Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0000899923-23-000097
Filing Date
2023-11-08
Accepted
2023-11-08 16:01:36
Documents
10
Effectiveness Date
2023-11-08

Document Format Files

Seq Description Document Type Size
1 S-3ASR maximum-sx3asr1112023.htm S-3ASR 229827
2 EX-FILING FEES maximum-ex107tosx3asr_draf.htm EX-FILING FEES 59188
3 EX-4.3 maximum-formofindenturesx3.htm EX-4.3 649172
4 EX-5.1 maximum-sx3asrex5opinionno.htm EX-5.1 34678
5 EX-23.1 maximum-ex231eyconsent.htm EX-23.1 2351
6 image_0a.jpg GRAPHIC 236
7 image_1a.jpg GRAPHIC 237
8 image_2a.jpg GRAPHIC 13598
9 image_3a.jpg GRAPHIC 166
10 opinion5_letterheadx118a.jpg GRAPHIC 116378
  Complete submission text file 0000899923-23-000097.txt   1156619
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275396 | Film No.: 231387675
SIC: 2835 In Vitro & In Vivo Diagnostic Substances